drugset

drugset / Trial / NCT01186432

Preliminary Safety and Efficacy of the PDS-1.0 in Patients With Neovascular Age Related Macular Degeneration (AMD)

NCT01186432 ↗

Phase 1 Completed 20 enrolled Forsight Vision4

NaSingle-groupOpen-labelTreatment

Summary

This study will evaluate the preliminary safety and efficacy of PDS 1.0 in patients with neovascular AMD.

Timeline

Start: 2010-08
Primary completion: 2012-05
Completion: 2014-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Ranibizumab	Monoclonal antibody	—	—

Indications